Blog

CALGARY, AB / ACCESS Newswire / August 29, 2025 / Tornado Infrastructure Equipment Ltd. (“Tornado” or the “Company”) (TSX-V:TGH)(OTCQX:TGHLF) today reported its unaudited condensed consolidated financial results for the three and six-month periods ended June 30, 2025. The unaudited condensed consolidated financial statements and related management discussion and analysis are available on the Company’s issuer profile in Canada on SEDAR+ at www.sedarplus.com, in the United States at www.otcmarkets.com and on the Company’s website www.tornadotrucks.com. All amounts reported in this news release are in thousands ($000’s CAD) except per share amounts.

Significant Developments and Q2/2025 Overview

1. Non-IFRS Financial Measures – EBITDAS is calculated by subtracting interest, tax, depreciation, amortization, stock-based compensation, gain/loss on foreign exchange, gain/loss on disposal of fixed assets and change in fair value of derivative financial instruments from earnings. EBITDAS per share (diluted) is calculated by dividing EBITDAS by the total number of diluted common shares. The terms EBITDAS and EBITDAS per share (diluted) are non-IFRS financial measures, and readers are cautioned that EBITDAS and EBITDAS per share (diluted) should not be considered to be more meaningful than net income determined in accordance with IFRS. The Company’s definition of EBITDAS and EBITDAS per share (diluted), are not standardized financial measures under IFRS and may not be comparable to similar financial measures used by other companies. While not IFRS measures, EBITDAS and EBITDAS per share (diluted), are used by management, creditors, analysts, investors and other financial stakeholders to assess the Company’s performance and management from a financial and operational perspective.

Financial and Operating Highlights (in CAD $000’s except outstanding common share and per share data)

(1) See “Non-IFRS Financial Measures” above.

Outlook

Management expects the Company’s production and sales of hydrovac trucks and profitability to continue to grow in 2025 for the following reasons:

• Expected continued spending on infrastructure in our industry across North America.

• The anticipated increased revenues and benefits from the strategic acquisition of CustomVac, including expanded product offerings, cross-selling opportunities, and improved supply chain efficiency.

• The continuing addition of new and innovative products that will support the infrastructure, telecommunications and oil and gas industries.

• The anticipated increasing revenues and benefits from the sales arrangement with its U.S. strategic partner, Custom Truck.

• The anticipated increase in production capacity and operating efficiencies resulting from the completion of the new production building constructed at the Red Deer facility, which is substantially complete and expected to commence operations in Q4/2025.

• The Company’s strategy to introduce new product lines to increase revenue by internal development and through synergistic business acquisitions.

• The Company’s commitment to continuous improvement of its hydrovac truck design which in the Company’s view will result in advantages over other hydrovac trucks currently offered in the market.

• The Company’s ability to continue to secure key manufacturing components, including chassis for customers, into future years through strategic supplier relationships.

• The Company’s strengthened dealer relationships in both Canada and U.S. to meet the expected demand increase.

• Expanded North American coverage for maintenance warranty and repair to serve customers better.

• Favorable impact of a strong USD on a significant portion of the Company’s U.S. sales, which supports improved gross margins on those transactions.

About Tornado Infrastructure Equipment Ltd.

Tornado is a pioneer and leader in the vacuum truck industry and has been the choice of utility and oilfield professionals with over 1,900 hydrovacs sold since 2008. The Company designs and manufactures hydrovac trucks and, through its subsidiary CustomVac, based in Nisku, Alberta, produces complementary vacuum and industrial equipment solutions, including units designed for the transportation of dangerous goods, and provides maintenance and field services to its customers. In addition, Tornado operates a heavy-duty truck maintenance facility in central Alberta. The Company sells its products to excavation service providers in the infrastructure, industrial construction, and oil and gas markets. Hydrovac trucks use high-pressure water and vacuum to safely penetrate and cut soil to expose critical infrastructure for repair and installation without damage. Hydrovac excavation methods are quickly becoming a standard in North America to safely excavate in urban areas and around critical infrastructure, significantly reducing infrastructure damage and related fatalities.

For more information about Tornado Infrastructure Equipment Ltd., visit www.tornadotrucks.com or contact:

Advisory

Certain statements contained in this news release constitute forward-looking statements. These statements relate to future events. All statements other than statements of historical fact are forward-looking statements. The use of the words “anticipates”, “should”, “may”, “will”, “strategy”, “estimate”, “expected”, “expects”, “believes” and other words of a similar nature are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Although Tornado believes these statements to be reasonable, no assurance can be given that these expectations will prove to be correct and such forward-looking statements included in this news release should not be unduly relied upon. Such statements include those with respect to:

• the Company’s outlook for the remainder of 2025;

• the expectation that the Company’s production, sales of hydrovac trucks and profitability for the remainder of 2025 will continue to grow;

• the expectation that the CustomVac acquisition presents synergy opportunities, including cross-selling across both customer bases, leveraging Tornado’s established sales channels in Canada and the United States to drive increased sales of CustomVac products, utilizing Tornado’s established and scalable supply chain to reduce production costs and improve efficiency;

• the expectation that the CustomVac acquisition provides a new product line for Tornado which includes units that are designed for the transportation of dangerous goods, which expands Tornado’s product offering to its customers;

• the expectation that the CustomVac acquisition will be profitable and immediately accretive to Tornado;

• the expectation that the new production facility in Red Deer will be operational in Q4/2025, enabling increased production capacity, enhanced efficiency, and improved working conditions;

• the anticipated increasing revenues and benefits from the sales arrangement with its U.S. strategic partner, Custom Truck;

• the expectation of continued spending on infrastructure in our industry across North America;

• the Company’s strategy to introduce new product lines to increase revenue by internal development and through synergistic business acquisitions.

• the expectation of continuing addition of new and innovative products that will support the infrastructure, telecommunications and oil and gas industries;

• management’s belief that the Company’s commitment to continuous improvement of its hydrovac truck design which in the Company’s view will result in advantages over other hydrovac trucks currently offered in the market;

• management’s belief in its continuing ability of securing key manufacturing components, including chassis, for customers into future years through strategic supplier relationships;

• management’s belief in the positive impact of strengthened dealer relationships in both Canada and U.S. to meet the expected demand increase;

• management’s belief in the positive impact of expanded North American coverage for maintenance warranty and repair; and

• the expected increased production levels for 2025.

These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Actual results could differ materially from those anticipated in these forward-looking statements as a result of prevailing economic conditions, and other factors, many of which are beyond the control of Tornado. Although Tornado believes these statements to be reasonable, no assurance can be given that these expectations will prove to be correct and such forward-looking statements included in this news release should not be unduly relied upon. The forward-looking statements contained in this news release represent Tornado’s expectations as of the date hereof and are subject to change after such date. Tornado disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as may be required by applicable securities regulations.

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

SOURCE: Tornado Infrastructure Equipment Ltd.

View the original press release on ACCESS Newswire

Sponsored TV commercials by NRx Pharma (NASDAQ:NRXP), Synergy CHC (NASDAQ:SNYR), ACURX Pharmaceuticals (NASDAQ:ACXP), and Sustainable Green Team (OTCQX:SGTM).

NEW YORK CITY, NEW YORK / ACCESS Newswire / August 29, 2025 / New to The Streets, one of the nation’s longest-running financial media platforms, today announced the broadcast of Episode 684 on Bloomberg Television, airing Saturday, August 30, 2025, 630 PM EST as sponsored programming.

This latest installment highlights a diverse lineup of industry leaders and innovators, including:

• TON Strategy Company (NASDAQ:VERB) – providing deep insights into corporate strategy and growth.

• Laser Photonics (NASDAQ:LASE) – unveiling advancements in cutting-edge photonics and industrial applications.

• Frank Aquila, Senior M&A Partner at Sullivan & Cromwell, delivering expert commentary on global dealmaking trends.

• Mercurity Fintech (NASDAQ:MFH) – exploring the future of digital finance and blockchain innovation.

The episode is further supported by sponsored television commercials from:

• NRx Pharma (NASDAQ:NRXP)

• Synergy CHC (NASDAQ:SNYR) The Focus Factor company

• ACURX Pharmaceuticals (NASDAQ:ACXP)

• Sustainable Green Team (OTCQX:SGTM)

“Episode 684 demonstrates our commitment to delivering compelling stories of strategy, innovation, and leadership,” said Vince Caruso, CEO and Co-Founder of New to The Street. “By combining Bloomberg’s reach with our unique platform, we continue to give public companies, thought leaders, and investors direct access to meaningful conversations that matter.”

About New to The Streets

Founded in 2009, New to The Streets is a premier financial media brand known for delivering predictable, guaranteed media exposure across television, digital, and social platforms. With over 3.35 million YouTube subscribers, broadcasts as sponsored programming on Bloomberg Television and Fox Business, and one of the most iconic billboard presences in Times Square, the brand has become a trusted platform for CEOs, executives, and innovators to share their stories.

Each week, New to The Streets combines long-form television interviews, national TV commercials, earned media placements, and digital amplification to deliver unmatched visibility. Over 600 shows have been produced, featuring leaders from industries ranging from biotech and fintech to energy, retail, and sustainability.

For more information, visit: www.NewToTheStreet.com

Media Contact: Monica Brennan, Monica@NewtoTheStreet.com

SOURCE: New To The Street

View the original press release on ACCESS Newswire

LAS VEGAS, NEVADA / ACCESS Newswire / August 29, 2025 / Gryphon Digital Mining, Inc. (Nasdaq:GRYP) (the “Company”), an innovative venture in the Bitcoin mining space, today announced that during its Special Meeting of Stockholders held on Wednesday, August 27, 2025, Gryphon stockholders approved the previously announced stock-for-stock merger transaction with American Bitcoin (the “Transaction”).

In connection with the Transaction and following approval by its Board of Directors (the “Board”), Gryphon will implement a reverse stock split (the “Reverse Stock Split”) of the Company’s outstanding shares of common stock at a ratio of 5-for-1. The Reverse Stock Split is being effected to satisfy Nasdaq’s listing requirements for minimum bid price in connection with the Transaction. The Reverse Stock Split will not impact the company’s market capitalization or the proportionate ownership interests of its stockholders, other than adjustments resulting from the treatment of fractional shares.

The Reverse Stock Split is expected to become effective as of 5:00 p.m. Eastern Time on September 2, 2025 (the “Split Effective Time”). Upon closing of the Transaction, the Company’s common stock is expected to begin trading on Nasdaq on a split-adjusted basis as Class A Common Stock, under the new CUSIP number 02462A104 and the ticker symbol “ABTC,” under the American Bitcoin brand.

At the Split Effective Time, every five issued and outstanding shares of the Company’s common stock will be combined automatically into one share of the Company’s common stock. No fractional shares will be issued in connection with the Reverse Stock Split, and stockholders who otherwise would be entitled to receive a fraction of a share because they hold a number of shares not evenly divisible by the Reverse Stock Split ratio will automatically be entitled to receive an additional fraction of a share of the Company’s common stock, to round up to the next whole share. Cash will not be paid for fractional shares.

The Reverse Stock Split will apply to shares of the Company’s common stock issuable upon exercise or conversion of the Company’s outstanding equity awards and warrants. Proportional adjustments will be made to the number of shares issuable upon the exercise of the Company’s outstanding equity awards, in accordance with the terms of such awards and its equity compensation plans, and the number of shares issuable upon the exercise of the Company’s outstanding warrants will be adjusted in accordance with the terms of such warrants.

The Reverse Stock Split will reduce the current number of outstanding shares of the Company’s common stock from approximately 82.8 million to approximately 16.6 million, not including issuances in connection with the Transaction.

The Company’s stockholders previously approved a reverse stock split at a special meeting of stockholders on May 24, 2025. The Reverse Stock Split and 5-for-1 ratio is within the range approved by the stockholders at such meeting. The Board approved the Reverse Stock Split at the 5-for-1 ratio on August 22, 2025. Additional information about the Reverse Stock Split can be found in the Company’s definitive proxy statement filed with the U.S. Securities and Exchange Commission (“SEC”) on April 21, 2025.

Registered stockholders who hold shares of the Company’s common stock in uncertificated form are not required to take any action to receive post-Reverse Stock Split shares, and holders of certificated shares will receive instructions from Continental Stock Transfer & Trust Company, the Company’s transfer agent. Stockholders owning shares through an account at a brokerage firm, bank, dealer, custodian or other similar organization acting as nominee will have their positions automatically adjusted to reflect the Reverse Stock Split, subject to such broker’s particular processes, and will not be required to take any action in connection with the Reverse Stock Split.

About the Company

Gryphon Digital Mining, Inc. is an innovative venture in the Bitcoin mining space. More information is available on www.gryphondigitalmining.com.

About American Bitcoin

American Bitcoin Corp. is a majority-owned subsidiary of Hut 8 Corp. focused exclusively on industrial-scale Bitcoin mining and strategic Bitcoin reserve development. The company combines Hut 8’s proven mining operations, cost-efficient infrastructure development capabilities, and disciplined approach to capital allocation with Eric Trump’s commercial acumen, capital markets expertise, and commitment to the advancement of decentralized financial systems. For more information, visit www.abtc.com.

Cautionary Note Regarding Forward-Looking Information

This press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Rule 175 promulgated thereunder, and Section 21E of the Securities Exchange Act of 1934, as amended, and Rule 3b-6 promulgated thereunder, which statements involve inherent risks and uncertainties. Examples of forward-looking statements, include, but are not limited to, the timing and completion of the Reverse Stock Split; the post-Reverse Stock Split trading on Nasdaq; the treatment of fractional shares of common stock in connection with the Reverse Stock Split and the adjustments applicable to the Company’s outstanding equity awards and warrants.

Forward-looking statements are not statements of historical fact, but instead represent management’s expectations, estimates, and projections regarding future events based on certain material factors and assumptions at the time the statement was made. While considered reasonable by management as of the date of this press release, such statements are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance, or achievements to be materially different from those expressed or implied by such forward-looking statements, including, but not limited to factors that may affect the future business, results, financial position and prospects of the Company. Additional factors that could cause results to differ materially from those described above can be found in the definitive proxy statement/prospectus with respect to the proposed transaction between the Company and American Bitcoin Corp. filed by the Company with the SEC on July 31, 2025, in the Company’s most recent annual report on Form 10-K for the fiscal year ended December 31, 2024 and in other documents filed by the Company with the SEC.

Investor Contact

Name: James Carbonara
Company: Hayden IR
Phone: (646) 755-7412
Email: james@haydenir.com

SOURCE: Gryphon Digital Mining, Inc.

View the original press release on ACCESS Newswire

ORLANDO, FL / ACCESS Newswire / August 29, 2025 / RedChip Companies will air interviews with NioCorp Developments Ltd. (Nasdaq:NB) and Atossa Therapeutics, Inc. (Nasdaq:ATOS) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV this Saturday, August 30, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.

Access the interviews in their entirety at:

• NB: https://www.redchip.com/assets/access/nb_access

• ATOS: https://www.redchip.com/assets/access/atos_access

In an exclusive interview, Mark Smith, Chairman, President, and CEO of NioCorp, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to discuss the company’s Elk Creek Project in Nebraska, a fully permitted $1.14 billion underground critical minerals mine expected to produce niobium, scandium, titanium, and potentially rare earth oxides essential to clean energy, aerospace, and defense applications. With all major permits secured, offtake agreements covering 75% of planned niobium output, and the largest scandium sales contract ever signed, NioCorp is positioned to establish America’s first mine-to-market scandium supply chain. Backed by strong state, federal, and local support-including a U.S. Department of Defense grant and an $800 million U.S. Export-Import Bank debt financing application-the Company is advancing toward construction of one of North America’s most strategic critical minerals projects. With robust economics, a projected 38-year mine life, and a management team with decades of rare earth and mining expertise, NioCorp is poised to deliver long-term value for shareholders as the U.S. and its allies race to secure critical mineral supply chains.

Dr. Steven Quay, CEO of Atossa Therapeutics, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to discuss Atossa’s strategic approach to redefining breast cancer treatment through its lead clinical candidate, (Z)-endoxifen – a next-generation SERM with best-in-class potential. With a focus on metastatic breast cancer, where current therapies often fall short, Atossa is advancing multiple Phase 2 studies that demonstrate strong clinical activity, improved tolerability, and a favorable safety profile. The presentation will highlight recent progress across key development programs, upcoming milestones, and how the Company’s differentiated science and capital-efficient model are designed to deliver both clinical impact and long-term shareholder value.

NB and ATOS are clients of RedChip Companies. Please read our full disclosure at https://www.redchip.com/legal/disclosures.

About NioCorp

NioCorp is developing a critical minerals project in Southeast Nebraska that is expected to produce niobium, scandium, and titanium (the “Elk Creek Project”). The Company also is evaluating the potential to produce several rare earths from the Elk Creek Project. Niobium is used to produce specialty alloys as well as High Strength, Low Alloy steel, which is a lighter, stronger steel used in automotive, structural, and pipeline applications. Scandium is a specialty metal that can be combined with aluminum to make alloys with increased strength and improved corrosion resistance. Scandium is also a critical component of advanced solid oxide fuel cells. Titanium is used in various lightweight alloys and is a key component of pigments used in paper, paint and plastics and is also used for aerospace applications, armor, and medical implants. Magnetic rare earths, such as neodymium, praseodymium, terbium, and dysprosium are critical to the making of neodymium-iron-boron magnets, which are used across a wide variety of defense and civilian applications.

About Atossa Therapeutics

Atossa Therapeutics, Inc. (Nasdaq:ATOS) is a clinical-stage biopharmaceutical company dedicated to transforming breast cancer treatment through innovative science and patient-focused solutions. The company’s lead product candidate, (Z)-endoxifen, is a highly potent SERM designed for use across the breast cancer spectrum, including prevention, neoadjuvant, adjuvant, and metastatic settings. Atossa is committed to advancing its robust clinical research programs to improve patient outcomes while creating sustainable value for shareholders. For more information, visit atossatherapeutics.com.

About RedChip Companies

RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. For 33 years, RedChip has delivered concrete, measurable results for its clients. Our newsletter, Small Stocks, Big Money™, is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, Small Stocks, Big Money™, which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more. RedChip also offers RedChat™, a proprietary AI-powered chatbot that analyzes SEC filings and corporate disclosures for all Nasdaq and NYSE-listed companies, giving investors instant, on-demand insights.

To learn more about RedChip’s products and services, please visit:

https://www.redchip.com/corporate/investor_relations

“Discovering Tomorrow’s Blue Chips Today”™

Follow RedChip on LinkedIn: https://www.linkedin.com/company/redchip/

Follow RedChip on Facebook: https://www.facebook.com/RedChipCompanies

Follow RedChip on Instagram: https://www.instagram.com/redchipcompanies/

Follow RedChip on Twitter: https://twitter.com/RedChip

Follow RedChip on YouTube: https://www.youtube.com/@redchip

Follow RedChip on Rumble: https://rumble.com/c/c-3068340

Subscribe to our Mailing List: https://www.redchip.com/newsletter/latest

Contact:

Dave Gentry
RedChip Companies Inc.
1-407-644-4256
info@redchip.com

SOURCE: RedChip Companies, Inc.

View the original press release on ACCESS Newswire

SINGAPORE, SG / ACCESS Newswire / August 29, 2025 / Immortal Dragons, the $40 million purpose-driven longevity fund, today announced its strategic investment in Frontier Bio, a biotechnology company at the forefront of biofabrication, drawing on a suite of technologies including 3D biofabrication, stem cells, organ-on-a-chip, and perfusion bioreactor technology. Their blood vessel technology addresses critical unmet medical needs in markets worth over $12 billion annually where current synthetic solutions show failure rates up to 65%.

The company’s innovative technology produces functional blood vessels that demonstrate superior performance including complete absence of thrombosis, significant cell infiltration, proper endothelium formation, and integration with surrounding tissue. Additionally, their tissues for in vitro testing include a microfluidicorgan-on-a-chip platforms that form human blood-brain barrier models, and a 3D bioprinted mini-lung, both designed to accelerate pre-clinical trials and deliver more accurate experimental results compared to animal testing.

Revolutionary Tissue Engineering

Frontier Bio’s breakthrough lies in their tissue-engineered blood vessels that eliminate the thrombosis risk plaguing current synthetic grafts. In successful large animal studies, the company’s vascular grafts demonstrated remarkable performance in the carotid artery: remaining patent with integration into surrounding tissue and crucially, showing no thrombosis or infection after 14 days of implantation.

This represents an exciting improvement over established synthetic vascular grafts, which typically show thrombosis in similar timeframes. Frontier Bio’s grafts are seeded with stem cells and demonstrate significant cell invasion throughout the graft with proper endothelium formation.

The technology provides multiple advantages: availability off-the-shelf availability, suitability for small diameter vessels, cellularization at implant, capability for complex vessel geometries. This combination of features positions Frontier Bio’s grafts as superior to both autologous vessels (limited availability) and current synthetic alternatives (poor performance, especially in small diameters under 5mm).

Blood vessels are essential for the survival and function of nearly all tissues. Frontier Bio develops both large-caliber vessels and self-branching microvasculature to meet this need.

“Refreshing to meet investors fluent in the field, technology, and related domains. Immortal Dragons acted on insight, not hype,” said Eric Bennett, CEO of Frontier Bio.

Strategic Alignment

The investment in Frontier Bio represents a targeted bet on solving organ failure – the leading cause of death for humans over 65. By developing scalable 3D biofabrication technology for functional organs and tissues, Frontier Bio addresses a $150 billion organ transplant market while advancing one of Immortal Dragons’ core thesis: that aging-related deaths can be prevented through replacement technology.

Currently, vast numbers of patients face lengthy organ transplant waiting lists, with many dying daily due to severe organ shortages. Frontier Bio’s platform could eliminate these bottlenecks by manufacturing organs on-demand using a patient’s own cells, reducing rejection risk and wait times. As Boyang Wang, founder of Immortal Dragons, explained: “3D Biofabrication represents a critical piece of replacement technologies, having the ability to manufacture specific organs and tissues on-demand provides the foundational infrastructure that makes biological part replacement possible.”

Looking Forward

Frontier Bio’s 3D biofabrication capabilities create powerful synergies across Immortal Dragons’ portfolio. The company’s organ printing technology directly supports whole-body replacement initiatives, providing the manufacturing infrastructure to produce replacement organs at scale. Additionally, the bioprinting platform’s tissue engineering capabilities support artificial womb development, creating complex vascular networks and specialized tissues required for external gestation systems. 3D biofabrication technology works synergistically with other replacement technologies, creating a comprehensive ecosystem of mutually reinforcing longevity solutions.

This vision of comprehensive longevity solutions resonates with leading researchers in the field. As Brian Kennedy, a distinguished professor and prominent longevity leader at the National University of Singapore, notes: “Immortal Dragons is making thoughtful, mission-driven investments in longevity by supporting high-impact science with long-term potential.”

About Immortal Dragons

Immortal Dragons (https://www.id.life/) is a purpose-driven longevity fund headquartered in Singapore. The fund invests in cutting-edge, high-impact technologies and currently supports more than 15 portfolio companies. Beyond conventional investments, the fund advances longevity advocacy through book translation and publishing, translation of longevity leaders’ talks, hosting a leading Chinese-language longevity podcast, and providing sponsorships and grants to longevity initiatives and conferences.

For Press Inquiries:

Boyang Wang
Founder, Immortal Dragons
press@id.life

SOURCE: Immortal Dragons

View the original press release on ACCESS Newswire